Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2 ‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - April 17, 2018 Category: Endocrinology Authors: Mikhail Kosiborod MD , K åre I. Birkeland MD , Matthew A. Cavender MD , Alex Z. Fu PhD , John P. Wilding MD , Kamlesh Khunti MD , Reinhard W. Holl MD , Anna Norhammar MD , Marit E. Jørgensen MD , Eric T. Wittbrodt Ph Source Type: research